Sereno Life Sciences Private Limited
About Sereno Life Sciences Private Limited
Data last updated:
Sereno Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2021PTC147686.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Manohar Aribandi and Venkateswara Rao Atluri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Villa No.09 13th Phase Indurfortune Fields Kukatpally, Hyderabad, Telangana, India – 500072.
Company details
Contact details
Sereno Life Sciences Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressVilla No.09 13th Phase Indurfortune Fields Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sereno Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sereno Life Sciences Private Limited, buy the company report.
Financials of Sereno Life Sciences Private Limited
FY 2025 filings availableSereno Life Sciences Private Limited reported revenue of ₹41 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 97% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sereno Life Sciences Private Limited, buy the company report.
Board of directors of Sereno Life Sciences Private Limited
Sereno Life Sciences has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manohar Aribandi | Director | 15 Oct 2021 | 5 Years 0 Months | Current |
| Venkateswara Rao Atluri Also directs: Prascon Infrastructure Private Limited | Director | 01 Nov 2021 | 5 Years 0 Months | Current |
| Bobba Raghavendra Rao Also directs: VK Ports Development Private Limited | Director | 11 Oct 2023 | 3 Years 0 Months | Current |
| Sivannarayana Chunduri | Director | 01 Nov 2021 | 5 Years 0 Months | Current |
| Manaswini Vemulapalli Also directs: Ritsa Pharma Private Limited | Director | 13 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Sereno Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mediculus Pharma Private Limited | ₹77 (FY 2024) | -100.0% | New Delhi, Delhi, India | |||
| Lakemedel Pharmaceuticals Private Limited | ₹72 (FY 2025) | -100.0% | Ahmedabad, Gujarat, India | |||
| Fuscient Labs Private Limited | ₹63 (FY 2023) | Bangalore, Karnataka, India | ||||
| Kautilya Laboratories Private Limited | ₹59 (FY 2025) | -100.0% | Hyderabad, Telangana, India | |||
| Bhagya Health Care Products Private Limited | ₹57 (FY 2018) | -100.0% | Navi Mumbai, Maharashtra, India | |||
| Sereno Life Sciences Private Limitedthis company | ₹41 (FY 2025) | -100.0% | Hyderabad, Telangana, India | |||
| Vav Biocos Private Limited | ₹37 (FY 2025) | -100.0% | Mumbai, Maharashtra, India | |||
| Pragna Fine Chem Private Limited | ₹32 (FY 2025) | -100.0% | Ankleshwar, Gujarat, India | |||
| Aretesynth Chemistry Private Limited | ₹25 (FY 2025) | -100.0% | Ahmedabad, Gujarat, India | |||
| Synbiopro Nutraceutix (OPC) Private Limited | ₹18 (FY 2024) | Mysore, Karnataka, India | ||||
| Gursimar Pharma Private Limited | ₹16 (FY 2025) | Ludhiana, Punjab, India |
To see the full peer comparison of Sereno Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sereno Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sereno Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sereno Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sereno Life Sciences Private Limited has 6 board changes on record since 2021: 5 appointments and 1 cessation. The latest: Bobba Raghavendra Rao was appointed as Director on 11 Oct 2023.
Frequently asked questions
Sereno Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2021 (5+ years old) and is registered under CIN U24110TG2021PTC147686.
Sereno Life Sciences has 5 current directors:
- Manohar Aribandi - Director
- Venkateswara Rao Atluri - Director
- Bobba Raghavendra Rao - Director
- Sivannarayana Chunduri - Director
- Manaswini Vemulapalli - Director
The latest financial statements of Sereno Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Sereno Life Sciences is U24110TG2021PTC147686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sereno Life Sciences was incorporated on 13 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sereno Life Sciences by revenue are Mediculus Pharma Private Limited, Lakemedel Pharmaceuticals Private Limited, Fuscient Labs Private Limited, Kautilya Laboratories Private Limited, Bhagya Health Care Products Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bobba Raghavendra Rao was appointed as Director on 11 Oct 2023. Ponduru Arun Prasad ceased to be Director on 11 Oct 2023. Sivannarayana Chunduri was appointed as Director on 01 Nov 2021. Sereno Life Sciences has 6 board changes on record in total.
The registered office of Sereno Life Sciences is at Villa No.09 13th Phase Indurfortune Fields Kukatpally, Hyderabad, Telangana, India – 500072.
Sereno Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Sereno Life Sciences can be reached at its registered office: Villa No.09 13th Phase Indurfortune Fields Kukatpally, Hyderabad, Telangana, India – 500072.
Sereno Life Sciences is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
